GE HealthCare today announced it is investing $80 million to expand contrast media production capacity in Norway. The investment will go toward increasing manufacturing capacity by 30% at its active pharmaceutical ingredients site in Lindesnes, Norway. As a result, the investment will create around 100 new jobs. GE HealthCare officials have committed to addressing the…

Cardinal Health (NYSE: CAH) today reported first-quarter results that beat the consensus forecast on Wall Street, sticking by its full-year EPS guidance. The Dublin, Ohio–based pharma and medtech giant earned $110 million, or 40¢ per share, off $49.6 billion in revenue for the quarter ended Sept. 30, 2022. The bottom line was less than half…

Fujifilm announced today that it is establishing a Seoul, South Korea–based subsidiary to accelerate its business growth in the cell culture media space. With paid-in capital of ₩300 million (roughly $250,000), the new subsidiary opens tomorrow. It will import cell culture media for bioproduction and advanced cell and gene therapies. Its goal through its direct…

The conglomerate Actylis made its debut today. The new brand integrates specialty ingredient maker Aceto with 10 specialty ingredient manufacturing and sourcing companies. The Port Washington, New York–based company will serve customers in various industries, including pharmaceutical and biopharmaceutical companies. It will also offer materials to companies specializing in nutrition, cosmetics, agriculture and specialty chemicals markets.…

Officials from the U.S. Department of Health and Human Services (HHS) have announced plans to provide up to 442,000 doses of the Jynneos vaccine from Bavarian Nordic A/S (OMX:BAVA) available across the country. In May, Biomedical Advanced Research and Development Authority (BARDA) said it had a contract with Bavarian Nordic worth up to $119 million to convert…

Cardinal Health (NYSE: CAH) today started air delivery of pharmaceutical products and medical supplies via Zipline drone in North Carolina. San Francisco-based Zipline won FAA Part 135 air carrier certification for the long-range flights earlier this month. The company flew its first commercial deliveries on June 22 with an initial 16-nautical-mile flight. The flights starting today…

Pfizer (NYSE: PFE) announced today that it will invest $120 million into its Kalamazoo, Michigan facility to support U.S.-based production of its COVID-19 antiviral Paxlovid (nirmatrelvir/ritonavir). The investment is expected to create more than 250 additional, high-skilled jobs at the Kalamazoo site. The money will expand the production of active pharmaceutical ingredient (API) and registered…

MedTrace Pharma announced the first person scanned in its Rapid-Water-Flow Phase 3 clinical trial, further testing its tech to bring 15 O-water to imaging. The first subject scan took place at Aarhus University Hospital in Denmark, using 15 O-water produced, dosed and injected through MedTrace’s P3 automated delivery system. The clinical trial aims to evaluate…

The NIH recently announced that it has started enrolling adults for a Phase 2 clinical trial evaluating various additional COVID-19 booster shots. NIH’s National Institute of Allergy and Infectious Diseases (NIAID) is sponsoring the COVID-19 Variant Immunologic Landscape (COVAIL) trial. “We are looking beyond the Omicron variant to determine the best strategy to protect against…

The tensions facing the global supply chain have been building in the pharmaceutical industry since even before the pandemic began, said Apurva Saraf, CEO of privately-held Cosette Pharmaceuticals (South Plainfield, New Jersey), in a recent interview. About five years ago, China, a central producer of active pharmaceutical ingredients (APIs), began shutting down tens of thousands…